SYMBOL:

    Up to 100 tickers separated by a space
Site Map FAQ Contact us Home Personalize
Company
Industry
Earnings
US Markets
Most Active
Portfolio
Tools
ETFs
Ratings
LEXICON PHARMACEUTICALS
(NQNM:LXRX Last Sale: 1.89 +0)
Fundamentals Charts Tech Analysis Industry Earnings
Company Profile   Details

Company Web Site
NQNM: (LXRX : $1.89)
$202,173 million Market Cap at Market Close, July 1, 2022
Employs 585.
Biomedics SubIndustry up .00% / Health Industry up .00% Today
8800 Technology Forest Place Research Report Earnings Snapshot - Last 11/04/18
The Woodlands, TX 77381 Fact Sheet
Phone: (281) 863-3000 Financial Statements
Peer Comparison
Annual Reports

William A. McMinn, Chmn., Arthur T. Sands, Pres./CEO, Julia P. Gregory, CFO
Discovers genes and sells genetic information to drug discovery firms through its OmniBank database. IPO at $22 April 6, 2000. Raised $220 million, selling 10 million shares, 21% of the outstanding. Lead Manager: J.P. Morgan. Formerly LEXICON GENETICS INC. until April 27, 2007.
Historical Charts    Technical Analysis
No Historical Data available for LXRX

Type of Stock Symbol Last Sale Last Close Net +/- % +/- Low High Volume 52wk Low 52wk High Shares(M)
Common LXRX $1.89 $1.89 0 .0 $1.81 $1.94 758,392 $1.81 $1.94 106,969,973
Capitalization
Earnings Summary ()
*** No Earnings Available***
-10121
Common Stock $202,173,249

Split, Dividend and Symbol Change Information
Date Symbol Transaction Dividend Split New Symbol
27-APR-07 LEXG Symbol Changed to LXRX

A
Google



QUICK NAVIGATION SITE SEARCH   Enter Keyword:
   
Home    Subscribe    Browser Help    Subscriber Services    B-to-B    Banks    Brokerage    Telco    Site Map    Legal    Contact/Email
Copyright © 1996 - 2024 Stock Smart with all rights reserved
Feed is currently being brought back up
Provided by Nanex